These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3917866)

  • 21. Cell surface receptors for lymphokines. I. The possible role of glycolipids as receptors for macrophage migration inhibitory factor (MIF) and macrophage activation factor (MAF).
    Poste G; Kirsh R; Fidler IJ
    Cell Immunol; 1979 Apr; 44(1):71-88. PubMed ID: 378418
    [No Abstract]   [Full Text] [Related]  

  • 22. A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor.
    Liu DY; Todd RF
    J Immunol; 1986 Jul; 137(2):448-55. PubMed ID: 3522731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding characteristics of fluoresceinated Lotus tetragonolobus fucolectin to macrophage populations which are either responsive or refractory to activation by lymphokine.
    Leu RW; Herriott MJ; Webb CF
    Immunobiology; 1985 Apr; 169(3):272-9. PubMed ID: 3888826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of macrophage complement receptor function in vitro. IV. The lymphokine that activates macrophage C3 receptors for phagocytosis binds to a fucose-bearing glycoprotein on the macrophage plasma membrane.
    Griffin FM; Mullinax PJ
    J Exp Med; 1984 Oct; 160(4):1206-18. PubMed ID: 6384418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
    Jobe O; Trinh HV; Kim J; Alsalmi W; Tovanabutra S; Ehrenberg PK; Peachman KK; Gao G; Thomas R; Kim JH; Michael NL; Alving CR; Rao VB; Rao M
    J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose.
    Bendtzen K
    Acta Allergol; 1975 Dec; 30(6):327-38. PubMed ID: 1106109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-fucose blocks MIF/MAF priming of rabbit alveolar macrophages for a PMA-induced oxidative response.
    Umehara K; Hayakawa H; Myrvik QN
    Cell Immunol; 1989 Mar; 119(1):67-72. PubMed ID: 2646027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival.
    Müller II; Chatterjee M; Schneider M; Borst O; Seizer P; Schönberger T; Vogel S; Müller KA; Geisler T; Lang F; Langer H; Gawaz M
    Int J Cardiol; 2014 Oct; 176(3):923-9. PubMed ID: 25194861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes.
    Wang JM; Sherry B; Fivash MJ; Kelvin DJ; Oppenheim JJ
    J Immunol; 1993 Apr; 150(7):3022-9. PubMed ID: 8454871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells.
    Pozzi LA; Weiser WY
    Cell Immunol; 1992 Dec; 145(2):372-9. PubMed ID: 1451185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor.
    Grewal T; Bartlett A; Burgess JW; Packer NH; Stanley KK
    Atherosclerosis; 1996 Mar; 121(1):151-63. PubMed ID: 8678920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
    Bunesova V; Lacroix C; Schwab C
    BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes.
    Klempner MS; Rocklin RE
    J Immunol; 1982 May; 128(5):2040-3. PubMed ID: 7037959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-dependent heterogeneity of human migration inhibitory factor.
    Weiser WY; David JR; Remold HG
    Cell Immunol; 1985 Jul; 93(2):532-40. PubMed ID: 2408769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glia cell stimulating factor (GSF): a new lymphokine. Part 2. Cellular sources and partial purification of human GSF.
    Fontana A; Otz U; De Weck AL; Grob PJ
    J Neuroimmunol; 1982 Jan; 2(1):73-81. PubMed ID: 6185536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen.
    Gregory SA; Kornbluth RS; Helin H; Remold HG; Edgington TS
    J Immunol; 1986 Nov; 137(10):3231-9. PubMed ID: 2945864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
    DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
    Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The major gangliosides of human peripheral blood monocytes/macrophages: absence of ganglio series structures.
    Yohe HC; Wallace PK; Berenson CS; Ye S; Reinhold BB; Reinhold VN
    Glycobiology; 2001 Oct; 11(10):831-41. PubMed ID: 11588159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of carbohydrates in thyrotropin binding sites.
    Pekonen F
    Horm Metab Res; 1980 Jul; 12(7):310-4. PubMed ID: 6249706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.